Back

PML-driven sumoylation of PML/RARA-bound co-repressors drives immortalization of primary hematopoietic progenitors

WU, H.-C.; Laplantine, E.; Esnault, C.; Kawakita, M.; Zhang, Y.; Geoffroy, M.-C.; de The, H.

2026-01-05 cancer biology
10.64898/2026.01.05.697641 bioRxiv
Show abstract

While acute promyelocytic leukemia (APL) is always driven by fusions involving one of the three retinoic acid receptors, why PML and RARA are the preferred fusion partners has remained largely unsettled. Here we demonstrate that corepressor (NCoR) binding onto the RARA moiety of PML/RARA is required for hematopoietic progenitor immortalization. We then establish that PML-mediated tethering of the UBC9 SUMO conjugating enzyme onto PML/RARA enforces SUMO2 conjugation of multiple RARA partner proteins, notably the NCoR complex, boosting its repressive power. PML mutants that fail to recruit UBC9 yield PML/RARA fusions that neither promote NCoR sumoylation nor transformation. Conversely, direct UBC9/RARA fusion drives both efficient NCoR sumoylation and immortalization. Sumoylation inhibitors re-activate retinoic acid target genes in PML/RARA-, but not RARA-, expressing progenitors and trigger APL differentiation. Thus, fusion of PML to RARA entails an unexpected key gain of function that boosts RARA-mediated transcriptional repression through sumoylation of PML/RARA-bound protein, explaining the recurrent implication of PML and RARA in APL pathogenesis.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
● 5828 papers in training set
Top 1%
25.9%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 26%
6.1%
Similar papers in this journal
3
Journal of Experimental Medicine
● 119 papers in training set
Top 0.5%
4.7%
Similar papers in this journal
4
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 12%
4.2%
Similar papers in this journal
5
EMBO Reports
○ 263 papers in training set
Top 0.9%
4.2%
Similar papers in this journal
6
Cell Reports
○ 1498 papers in training set
Top 10%
3.9%
7
Genes & Development
● 90 papers in training set
Top 0.3%
3.3%
50% of probability mass above
8
Life Science Alliance
● 285 papers in training set
Top 1%
3.1%
9
Science Advances
● 1243 papers in training set
Top 13%
2.7%
10
Molecular Cell
○ 350 papers in training set
Top 2%
2.7%
11
Blood
● 74 papers in training set
Top 0.7%
2.3%
12
Molecular Cancer Research
● 49 papers in training set
Top 0.6%
1.9%
13
iScience
○ 1154 papers in training set
Top 19%
1.7%
14
Cells
○ 249 papers in training set
Top 3%
1.7%
15
Stem Cell Reports
○ 130 papers in training set
Top 1%
1.7%
16
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.4%
1.6%
17
The EMBO Journal
○ 309 papers in training set
Top 4%
1.5%
18
Oncogenesis
○ 12 papers in training set
Top 0.2%
1.1%
19
Cancer Research
● 130 papers in training set
Top 3%
1.1%
20
Journal of Cell Biology
● 392 papers in training set
Top 3%
1.1%
21
Cancer Discovery
● 66 papers in training set
Top 2%
1.0%
22
Journal of Clinical Investigation
● 179 papers in training set
Top 5%
1.0%
23
Scientific Reports
○ 3612 papers in training set
Top 70%
1.0%
24
Oncogene
○ 85 papers in training set
Top 2%
0.8%
25
Communications Biology
○ 993 papers in training set
Top 32%
0.8%
26
Leukemia
○ 42 papers in training set
Top 0.9%
0.6%
27
Frontiers in Cell and Developmental Biology
○ 233 papers in training set
Top 6%
0.6%
28
Cell Death & Differentiation
○ 48 papers in training set
Top 2%
0.6%
29
EMBO Molecular Medicine
○ 95 papers in training set
Top 4%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.